title: Vitamin E treatment of tardive dyskinesia.
abstract: OBJECTIVE
  The authors studied the effects of vitamin E treatment of tardive dyskinesia; earlier studies have produced contradictory results.
  
  
  METHODS
  Twenty-eight patients with tardive dyskinesia were treated in a double-blind, parallel-group comparison study of 8-12 weeks of treatment with vitamin E (1600 IU/day) or matching placebo capsules.
  
  
  RESULTS
  The Abnormal Involuntary Movement Scale scores of the patients treated with vitamin E improved significantly compared to the scores of the patients given placebo.
  
  
  CONCLUSIONS
  These results support earlier findings of the efficacy of vitamin E in treating tardive dyskinesia.
authors.affiliation: Psychiatry Service, New York Department of Veterans Affairs Medical Center, NY 10010.
authors.forename: L A
authors.initials: LA
authors.lastname: Adler
authors.forename: E
authors.initials: E
authors.lastname: Peselow
authors.forename: J
authors.initials: J
authors.lastname: Rotrosen
authors.forename: E
authors.initials: E
authors.lastname: Duncan
authors.forename: M
authors.initials: M
authors.lastname: Lee
authors.forename: M
authors.initials: M
authors.lastname: Rosenthal
authors.forename: B
authors.initials: B
authors.lastname: Angrist
mesh_terms: D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000009:adverse effects; D004311:Double-Blind Method; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy; D014810:Vitamin E / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D010919:Placebos; D014810:Vitamin E